Nevro Corp (NYSE:NVRO)

44.65
BATS BZX Real-Time Price
As of 2:07pm ET
 +0.82 / +1.87%
Today’s Change
39.41
Today|||52-Week Range
168.19
-44.92%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.7B

Company Description

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.

Contact Information

Nevro Corp.
1800 Bridge Parkway
Redwood City California 94065
P:(650) 251-0005
Investor Relations:

Employees

Shareholders

Mutual fund holders63.95%
Other institutional38.90%
Individual stakeholders20.26%

Top Executives

D. Keith GrossmanChairman, President & Chief Executive Officer
Roderick H. MacLeodChief Financial Officer
David CarawayChief Medical Officer
Christopher ChristoforouVice President-Technical Operations
Stephen SmithVice President-Information Technology